Teva sues Perrigo over ProAir asthma inhaler patents
Globes Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) unit Teva Branded Pharmaceutical Products R&D Inc. has filed patent infringement suit with the US District Court for the District of Delaware against Perrigo Company (Nasdaq:PRGO; … |
View full post on asthma – Google News